potassium sodium hydrogen citrate

Small moleculeexperimental

Clinical trial activity

2 trials · 2 clinical orgs · 0 marketing orgs

Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0

Earliest trial started Sep 30, 2019 (NCT03924596)

Timeline

2010s

  1. Jan 1, 2019

    Earliest Phase 1 Sponsor(trial)

Indications

Mechanism of action

  • Unspecified targetCHELATING AGENT

    Chelating agent

Chemistry & pharmacology

Loading structure…

SMILES

O.O=C([O-])CC(O)(CC(=O)[O-])C(=O)O.O=C([O-])CC(O)(CC(=O)[O-])C(=O)O.O=C([O-])CC(O)(CC(=O)[O-])C(=O)O.O=C([O-])CC(O)(CC(=O)[O-])C(=O)[O-].O=C([O-])CC(O)(CC(=O)[O-])C(=O)[O-].[K+].[K+].[K+].[K+].[K+].[K+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+]
Mol. weight
1339.06 g/mol
Chirality
Achiral Molecule
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT04352153N/AApr 1, 2020Huazhong University of Science and Technology
NCT03924596Phase 1/Phase 2 (Phase 2)Sep 30, 2019Sultan Qaboos University
Showing 2 of 2 trials
Page 1 / 1

Organizations

Research & Development (2)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Huazhong University of Science and TechnologyAcademic/Hospital1112020
Sultan Qaboos UniversityAcademic/Hospital1112019
2 organizations
Page 1 / 1